Related references
Note: Only part of the references are listed.Central nervous system myeloid cells as drug targets: current status and translational challenges
Knut Biber et al.
NATURE REVIEWS DRUG DISCOVERY (2016)
pDC therapy induces recovery from EAE by recruiting endogenous pDC to sites of CNS inflammation
Fernanda V. Duraes et al.
JOURNAL OF AUTOIMMUNITY (2016)
Pivotal Role for CD16+ Monocytes in Immune Surveillance of the Central Nervous System
Anne Waschbisch et al.
JOURNAL OF IMMUNOLOGY (2016)
Effects of fumarates on circulating and CNS myeloid cells in multiple sclerosis
Mackenzie A. Michell-Robinson et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2016)
Tracking CNS and systemic sources of oxidative stress during the course of chronic neuroinflammation
Agata A. Mossakowski et al.
ACTA NEUROPATHOLOGICA (2015)
Microglia: Multitasking Specialists of the Brain
Alessandra Maria Casano et al.
DEVELOPMENTAL CELL (2015)
The Cytokine GM-CSF Drives the Inflammatory Signature of CCR2+ Monocytes and Licenses Autoimmunity
Andrew L. Croxford et al.
IMMUNITY (2015)
Activation Status of Human Microglia Is Dependent on Lesion Formation Stage and Remyelination in Multiple Sclerosis
Laura A. N. Peferoen et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2015)
FTY720 (fingolimod) treatment tips the balance towards less immunogenic antigen-presenting cells in patients with multiple sclerosis
Felix Luessi et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
Transcription factor Nr4a1 couples sympathetic and inflammatory cues in CNS-recruited macrophages to limit neuroinflammation
Iftach Shaked et al.
NATURE IMMUNOLOGY (2015)
IFN-γ ameliorates autoimmune encephalomyelitis by limiting myelin lipid peroxidation
Rebecca A. Sosa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Proinflammatory GM-CSF-producing B cells in multiple sclerosis and B cell depletion therapy
Rui Li et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
GM-CSF in Neuroinflammation: Licensing Myeloid Cells for Tissue Damage
Andrew L. Croxford et al.
TRENDS IN IMMUNOLOGY (2015)
FTY720 (fingolimod) treatment tips the balance towards less immunogenic antigen-presenting cells in patients with multiple sclerosis
Felix Luessi et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors
Elisa Gomez Perdiguero et al.
NATURE (2015)
Reduction of CD8+ T lymphocytes in multiple sclerosis patients treated with dimethyl fumarate
Collin M. Spencer et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2015)
Microglia: unique and common features with other tissue macrophages
Marco Prinz et al.
ACTA NEUROPATHOLOGICA (2014)
Mode of action and clinical studies with alemtuzumab
Joanne L. Jones et al.
EXPERIMENTAL NEUROLOGY (2014)
Macrophage Activation and Polarization: Nomenclature and Experimental Guidelines
Peter J. Murray et al.
IMMUNITY (2014)
Transcriptome-Based Network Analysis Reveals a Spectrum Model of Human Macrophage Activation
Jia Xue et al.
IMMUNITY (2014)
Differential roles of microglia and monocytes in the inflamed central nervous system
Ryo Yamasaki et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
Interactions Between Microglia and T Cells in Multiple Sclerosis Pathobiology
Megan Strachan-Whaley et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2014)
Glutathione PEGylated liposomal methylprednisolone (2B3-201) attenuates CNS inflammation and degeneration in murine myelin oligodendrocyte glycoprotein induced experimental autoimmune encephalomyelitis
De-Hyung Lee et al.
JOURNAL OF NEUROIMMUNOLOGY (2014)
Interferon Beta and Vitamin D Synergize to Induce Immunoregulatory Receptors on Peripheral Blood Monocytes of Multiple Sclerosis Patients
Anne Waschbisch et al.
PLOS ONE (2014)
Laquinimod reduces neuroaxonal injury through inhibiting microglial activation
Manoj Kumar Mishra et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2014)
Microglial nodules in early multiple sclerosis white matter are associated with degenerating axons
Shailender Singh et al.
ACTA NEUROPATHOLOGICA (2013)
Extracellular matrix metalloproteinase inducer shows active perivascular cuffs in multiple sclerosis
Smriti M. Agrawal et al.
BRAIN (2013)
Modulation of dendritic cell properties by laquinimod as a mechanism for modulating multiple sclerosis
Valerie Jolivel et al.
BRAIN (2013)
The Benefits and Detriments of Macrophages/Microglia in Models of Multiple Sclerosis
Khalil S. Rawji et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2013)
Modulation of immune function occurs within hours of therapy initiation for multiple sclerosis
Chris L. Ayers et al.
CLINICAL IMMUNOLOGY (2013)
Drugs in Development for Relapsing Multiple Sclerosis
Rehiana Ali et al.
DRUGS (2013)
Circulating Monocytes Are Reduced by Sphingosine-1-Phosphate Receptor Modulators Independently of S1P3
Nuruddeen D. Lewis et al.
JOURNAL OF IMMUNOLOGY (2013)
Assessment of changes in immune measures of multiple sclerosis patients treated with laquinimod
Brett T. Lund et al.
JOURNAL OF NEUROIMMUNOLOGY (2013)
The effects of teriflunomide on lymphocyte subpopulations in human peripheral blood mononuclear cells in vitro
Li Li et al.
JOURNAL OF NEUROIMMUNOLOGY (2013)
Fingolimod phosphate promotes the neuroprotective effects of microglia
Hiromi Noda et al.
JOURNAL OF NEUROIMMUNOLOGY (2013)
Reduction of microglial activity in a model of multiple sclerosis by dipyridamole
Scott Sloka et al.
JOURNAL OF NEUROINFLAMMATION (2013)
Macrophages in inflammatory multiple sclerosis lesions have an intermediate activation status
Daphne Y. S. Vogel et al.
JOURNAL OF NEUROINFLAMMATION (2013)
Dendritic cell, monocyte and T cell activation and response to glatiramer acetate in multiple sclerosis
F. Sellebjerg et al.
MULTIPLE SCLEROSIS JOURNAL (2013)
A new type of microglia gene targeting shows TAK1 to be pivotal in CNS autoimmune inflammation
Tobias Goldmann et al.
NATURE NEUROSCIENCE (2013)
Microglia emerge from erythromyeloid precursors via Pu.1- and Irf8-dependent pathways
Katrin Kierdorf et al.
NATURE NEUROSCIENCE (2013)
Sphingosine 1-phosphate receptor 3 regulates recruitment of anti-inflammatory monocytes to microvessels during implant arteriogenesis
Anthony O. Awojoodu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Communication between pathogenic T cells and myeloid cells in neuroinflammatory disease
Laura Codarri et al.
TRENDS IN IMMUNOLOGY (2013)
Effects of Vitamin D3, Calcipotriol and FTY720 on the Expression of Surface Molecules and Cytolytic Activities of Human Natural Killer Cells and Dendritic Cells
Zaidoon Al-Jaderi et al.
TOXINS (2013)
Teriflunomide attenuates immunopathological changes in the Dark Agouti rat model of experimental autoimmune encephalomyelitis
Garth E. Ringheim et al.
FRONTIERS IN NEUROLOGY (2013)
Kinetics of Proinflammatory Monocytes in a Model of Multiple Sclerosis and Its Perturbation by Laquinimod
Manoj K. Mishra et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Modulation of Autoimmune Demyelination by Laquinimod via Induction of Brain-Derived Neurotrophic Factor
Jan Thoene et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Natalizumab treatment perturbs memory- and marginal zone-like B-cell homing in secondary lymphoid organs in multiple sclerosis
Raquel Planas et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2012)
Dimethyl Fumarate Inhibits Dendritic Cell Maturation via Nuclear Factor κB (NF-κB) and Extracellular Signal-regulated Kinase 1 and 2 (ERK1/2) and Mitogen Stress-activated Kinase 1 (MSK1) Signaling
Haiyan Peng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Mechanisms of Glucocorticoids in the Control of Neuroinflammation
N. Schweingruber et al.
JOURNAL OF NEUROENDOCRINOLOGY (2012)
Decreased microglial activation in MS patients treated with glatiramer acetate
John N. Ratchford et al.
JOURNAL OF NEUROLOGY (2012)
Increased PK11195 PET binding in the cortex of patients with MS correlates with disability
Marios Politis et al.
NEUROLOGY (2012)
Heterogeneity of cortical lesions in multiple sclerosis Clinical and pathologic implications
Evert-Jan Kooi et al.
NEUROLOGY (2012)
Laquinimod, a Quinoline-3-Carboxamide, Induces Type II Myeloid Cells That Modulate Central Nervous System Autoimmunity
Ulf Schulze-Topphoff et al.
PLOS ONE (2012)
Glatiramer Acetate Increases Phagocytic Activity of Human Monocytes In Vitro and in Multiple Sclerosis Patients
Refik Pul et al.
PLOS ONE (2012)
A Lineage of Myeloid Cells Independent of Myb and Hematopoietic Stem Cells
Christian Schulz et al.
SCIENCE (2012)
Fibrinogen-induced perivascular microglial clustering is required for the development of axonal damage in neuroinflammation
Dimitrios Davalos et al.
NATURE COMMUNICATIONS (2012)
Plasmacytoid Dendritic Cells: Recent Progress and Open Questions
Boris Reizis et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 29 (2011)
Radical changes in multiple sclerosis pathogenesis
Jack van Horssen et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2011)
Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway
Ralf A. Linker et al.
BRAIN (2011)
Preactive Multiple Sclerosis Lesions Offer Novel Clues for Neuroprotective Therapeutic Strategies
Johannes M. van Noort et al.
CNS & Neurological Disorders-Drug Targets (2011)
The Yin and Yang of Microglia
Melinda Czeh et al.
DEVELOPMENTAL NEUROSCIENCE (2011)
Fumarates improve psoriasis and multiple sclerosis by inducing type II dendritic cells
Kamran Ghoreschi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Liposomal Encapsulation of Glucocorticoids Alters Their Mode of Action in the Treatment of Experimental Autoimmune Encephalomyelitis
Nils Schweingruber et al.
JOURNAL OF IMMUNOLOGY (2011)
Dimethyl Fumarate, an Immune Modulator and Inducer of the Antioxidant Response, Suppresses HIV Replication and Macrophage-Mediated Neurotoxicity: A Novel Candidate for HIV Neuroprotection
Stephanie A. Cross et al.
JOURNAL OF IMMUNOLOGY (2011)
Glatiramer Acetate Modulates TNF-α and IL-10 Secretion in Microglia and Promotes Their Phagocytic Activity
Refik Pul et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2011)
Differential responses of human microglia and blood-derived myeloid cells to FTY720
Bryce A. Durafourt et al.
JOURNAL OF NEUROIMMUNOLOGY (2011)
Fingolimod modulates microglial activation to augment markers of remyelination
Samuel J. Jackson et al.
JOURNAL OF NEUROINFLAMMATION (2011)
EMMPRIN: A Novel Regulator of Leukocyte Transmigration into the CNS in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis
Smriti M. Agrawal et al.
JOURNAL OF NEUROSCIENCE (2011)
Altered M1/M2 activation patterns of monocytes in severe relapsing experimental rat model of multiple sclerosis. Amelioration of clinical status by M2 activated monocyte administration
Joanna Mikita et al.
MULTIPLE SCLEROSIS JOURNAL (2011)
RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation
Laura Codarri et al.
NATURE IMMUNOLOGY (2011)
The encephalitogenicity of TH17 cells is dependent on IL-1-and IL-23-induced production of the cytokine GM-CSF
Mohamed El-Behi et al.
NATURE IMMUNOLOGY (2011)
A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis
Ivana Nikic et al.
NATURE MEDICINE (2011)
Infiltrating monocytes trigger EAE progression, but do not contribute to the resident microglia pool
Bahareh Ajami et al.
NATURE NEUROSCIENCE (2011)
Heterogeneity of CNS myeloid cells and their roles in neurodegeneration
Marco Prinz et al.
NATURE NEUROSCIENCE (2011)
Microglial cell origin and phenotypes in health and disease
Kaoru Saijo et al.
NATURE REVIEWS IMMUNOLOGY (2011)
Mechanism of Action of Oral Fingolimod (FTY720) in Multiple Sclerosis
Jerold Chun et al.
CLINICAL NEUROPHARMACOLOGY (2010)
The Potential Role of B Cell-Targeted Therapies in Multiple Sclerosis
Aaron Boster et al.
DRUGS (2010)
Alternative Activation of Macrophages: Mechanism and Functions
Siamon Gordon et al.
IMMUNITY (2010)
IFN-beta Inhibits Dendritic Cell Migration through STAT-1-Mediated Transcriptional Suppression of CCR7 and Matrix Metalloproteinase 9
Jui-Hung Yen et al.
JOURNAL OF IMMUNOLOGY (2010)
Dimethylfumarate inhibits microglial and astrocytic inflammation by suppressing the synthesis of nitric oxide, IL-1β, TNF-α and IL-6 in an in-vitro model of brain inflammation
Henrik Wilms et al.
JOURNAL OF NEUROINFLAMMATION (2010)
Activated Microglia Mediate Axoglial Disruption That Contributes to Axonal Injury in Multiple Sclerosis
Owain W. Howell et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2010)
Interferon-β mechanisms of action in multiple sclerosis
Suhayl Dhib-Jalbut et al.
NEUROLOGY (2010)
Inflammation in Neurological Disorders: A Help or a Hindrance?
V. Wee Yong
NEUROSCIENTIST (2010)
Development of Monocytes, Macrophages, and Dendritic Cells
Frederic Geissmann et al.
SCIENCE (2010)
Fate Mapping Analysis Reveals That Adult Microglia Derive from Primitive Macrophages
Florent Ginhoux et al.
SCIENCE (2010)
The impact of the extracellular matrix on inflammation
Lydia Sorokin
NATURE REVIEWS IMMUNOLOGY (2010)
Localizing Central Nervous System Immune Surveillance: Meningeal Antigen-Presenting Cells Activate T Cells during Experimental Autoimmune Encephalomyelitis
Pia Kivisakk et al.
ANNALS OF NEUROLOGY (2009)
Interferon β induces mature dendritic cell apoptosis through caspase-11/caspase-3 activation
Jui-Hung Yen et al.
BLOOD (2009)
Circulating Ly-6C+ myeloid precursors migrate to the CNS and play a pathogenic role during autoimmune demyelinating disease
Irah L. King et al.
BLOOD (2009)
A type I interferon signature in monocytes is associated with poor response to interferon-β in multiple sclerosis
M. Comabella et al.
BRAIN (2009)
CCR2Ly-6Chi monocytes are crucial for the effector phase of autoimmunity in the central nervous system
Alexander Mildner et al.
BRAIN (2009)
Ocrelizumab: a step forward in the evolution of B-cell therapy
Fariha Kausar et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2009)
IFN-β Inhibits Human Th17 Cell Differentiation
Vinod S. Ramgolam et al.
JOURNAL OF IMMUNOLOGY (2009)
Changes in circulating dendritic cells and B-cells in patients with multiple sclerosis relapse during corticosteroid therapy
Mitosek-Szewczyk Krystyna et al.
JOURNAL OF NEUROIMMUNOLOGY (2009)
Glatiramer acetate increases IL-1 receptor antagonist but decreases T cell-induced IL-1β in human monocytes and multiple sclerosis
Danielle Burger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Sphingosine-1-phosphate induces an antiinflammatory phenotype in macrophages
Jeniter E. Hughes et al.
CIRCULATION RESEARCH (2008)
Pharmacological treatment of early multiple sclerosis
Olaf Stueve et al.
DRUGS (2008)
Distinct and nonredundant in vivo functions of IFNAR on myeloid cells limit autoimmunity in the central nervous system
Marco Prinz et al.
IMMUNITY (2008)
The type IIFN induction pathway constrains Th17-mediated autoimmune inflammation in mice
Beichu Guo et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Microglia cells protect neurons by direct engulfment of invading neutrophil granulocytes: A new mechanism of CNS immune privilege
Jens Neumann et al.
JOURNAL OF NEUROSCIENCE (2008)
Reduction of free radicals in multiple sclerosis:: effect of glatiramer acetate (Copaxone®)
C. Iarlori et al.
MULTIPLE SCLEROSIS (2008)
Persistent activation of microglia is associated with neuronal dysfunction of callosal projecting pathways and multiple sclerosis-like lesions in relapsing -: remitting experimental autoimmune encephalomyelitis
Stine Rasmussen et al.
BRAIN (2007)
Glucocorticoid treatment reduces T-bet and pSTAT1 expression in mononuclear cells from relapsing remitting multiple sclerosis patients
Giovanni Frisullo et al.
CLINICAL IMMUNOLOGY (2007)
Type II monocytes modulate T cell-mediated central nervous system autoimmune disease
Martin S. Weber et al.
NATURE MEDICINE (2007)
Interferon-β regulates cytokines and BDNF:: greater effect in relapsing than in progressive multiple sclerosis
K. Hamomcioglu et al.
MULTIPLE SCLEROSIS JOURNAL (2007)
Metalloproteinases are enriched in microglia compared with leukocytes and they regulate cytokine levels in activated microglia
Robert K. Nuttall et al.
GLIA (2007)
GM-CSF production by autoreactive T cells is required for the activation of microglial cells and the onset of experimental autoimmune encephalomyelitis
Eugene D. Ponomarev et al.
JOURNAL OF IMMUNOLOGY (2007)
Tumor necrosis factor-α induces neurotoxicity via glutamate release from hemichannels of activated microglia in an autocrine manner
Hideyuki Takeuchi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Fumaric acid esters are effective in chronic experimental autoimmune encephalomyelitis and suppress macrophage infiltration
S. Schilling et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2006)
Dystroglycan is selectively cleaved at the parenchymal basement membrane at sites of leukocyte extravasation in experimental autoimmune encephalomyelitis
S Agrawal et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
The window of therapeutic opportunity in multiple sclerosis
AJ Coles et al.
JOURNAL OF NEUROLOGY (2006)
Monocyte and macrophage heterogeneity
S Gordon et al.
NATURE REVIEWS IMMUNOLOGY (2005)
Cortical demyelination and diffuse white matter injury in multiple sclerosis
A Kutzelnigg et al.
BRAIN (2005)
Microorlial cell activation and proliferation precedes the onset of CNS autoimmunity
ED Ponomarev et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2005)
Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo
A Nimmerjahn et al.
SCIENCE (2005)
The immunomodulator FTY720 interferes with effector functions of human monocyte-derived dendritic cells
H Müller et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2005)
Experimental autoimmune encephalomyelitis repressed by microglial paralysis
FL Heppner et al.
NATURE MEDICINE (2005)
Multiple sclerosis:: expression of CD1a and production of IL-12 p70 and IFN-γ by blood mononuclear cells in patients on combination therapy with IFN-β and glatiramer acetate compared to monotherapy with IFN-β
Y Hussien et al.
MULTIPLE SCLEROSIS JOURNAL (2004)
Interferon-β up-regulates the expression of co-stimulatory molecules CD80, CD86 and CD40 on monocytes:: significance for treatment of multiple sclerosis
S Marckmann et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2004)
Multiple sclerosis:: glatiramer acetate inhibits monocyte reactivity in vitro and in vivo
MS Weber et al.
BRAIN (2004)
Modulation of effector cell functions in experimental autoimmune encephalomyelitis by leflunomide - mechanisms independent of pyrimidine depletion
T Korn et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2004)
Type 2 monocyte and microglia differentiation mediated by glatiramer acetate therapy in patients with multiple sclerosis
HJ Kim et al.
JOURNAL OF IMMUNOLOGY (2004)
Interferon-β enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation:: relevance for the immune modulatory effect in multiple sclerosis
B Schreiner et al.
JOURNAL OF NEUROIMMUNOLOGY (2004)
Interferon-gamma switches monocyte differentiation from dendritic cells to macrophages
Y Delneste et al.
BLOOD (2003)
Regulation by interferon beta-1 a of reactive oxygen metabolites production by lymphocytes and monocytes and serum sulfhydryls in relapsing multiple sclerosis patients
M Lucas et al.
NEUROCHEMISTRY INTERNATIONAL (2003)
Modulation of monocytes matrix metalloproteinase-2, MT1-MMP and TIMP-2 by interferon-γ and -β:: implications to multiple sclerosis
Y Galboiz et al.
JOURNAL OF NEUROIMMUNOLOGY (2002)
Immunopathology of secondary-progressive multiple sclerosis
JW Prineas et al.
ANNALS OF NEUROLOGY (2001)
Increased percentage of IL-12+monocytes in the blood correlates with the presence of active MRI lesions in MS
K Makhlouf et al.
JOURNAL OF NEUROIMMUNOLOGY (2001)
Metalloproteinases in biology and pathology of the nervous system
VW Yong et al.
NATURE REVIEWS NEUROSCIENCE (2001)
Monocytes in multiple sclerosis: phenotype and cytokine profile
M Kouwenhoven et al.
JOURNAL OF NEUROIMMUNOLOGY (2001)
Immunomodulatory effects of interferon beta-1a in multiple sclerosis
ZG Liu et al.
JOURNAL OF NEUROIMMUNOLOGY (2001)
Share Paper
